These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15112460)

  • 1. Convergences in course of illness and treatments of the epilepsies and recurrent affective disorders.
    Post RM; Weiss SR
    Clin EEG Neurosci; 2004 Jan; 35(1):14-24. PubMed ID: 15112460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A speculative model of affective illness cyclicity based on patterns of drug tolerance observed in amygdala-kindled seizures.
    Post RM; Weiss SR
    Mol Neurobiol; 1996 Aug; 13(1):33-60. PubMed ID: 8892335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affective disorder and epilepsy comorbidity: implications for development of treatments, preventions and diagnostic approaches.
    Jobe PC
    Clin EEG Neurosci; 2004 Jan; 35(1):53-68. PubMed ID: 15112464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kindling: separate vs. shared mechanisms in affective disorders and epilepsy.
    Weiss SR; Post RM
    Neuropsychobiology; 1998 Oct; 38(3):167-80. PubMed ID: 9778605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shared mechanisms of antidepressant and antiepileptic treatments: drugs and devices.
    Jobe PC
    Clin EEG Neurosci; 2004 Jan; 35(1):25-37. PubMed ID: 15112461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and future therapeutic opportunities in the comorbidity between the epilepsies and affective disorders.
    Jobe PC
    Clin EEG Neurosci; 2004 Jan; 35(1):1-3. PubMed ID: 15112458
    [No Abstract]   [Full Text] [Related]  

  • 7. The recognition and management of mood disorders as a comorbidity of epilepsy.
    Barry JJ
    Epilepsia; 2003; 44 Suppl 4():30-40. PubMed ID: 12823567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Nefiracetam, a novel pyrrolidone-type nootropic agent, on the amygdala-kindled seizures in rats.
    Kitano Y; Komiyama C; Makino M; Kasai Y; Takasuna K; Kinoshita M; Yamazaki O; Takazawa A; Yamauchi T; Sakurada S
    Epilepsia; 2005 Oct; 46(10):1561-8. PubMed ID: 16190926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do the epilepsies, pain syndromes, and affective disorders share common kindling-like mechanisms?
    Post RM
    Epilepsy Res; 2002 Jun; 50(1-2):203-19. PubMed ID: 12151130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance to the prophylactic effects of carbamazepine and related mood stabilizers in the treatment of bipolar disorders.
    Post RM; Weiss SR
    CNS Neurosci Ther; 2011 Dec; 17(6):649-60. PubMed ID: 21159150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why are complex partial seizures intractable?
    Burnham WM
    Adv Exp Med Biol; 2002; 497():107-10. PubMed ID: 11993726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levetiracetam prevents changes in levels of brain-derived neurotrophic factor and neuropeptide Y mRNA and of Y1- and Y5-like receptors in the hippocampus of rats undergoing amygdala kindling: implications for antiepileptogenic and mood-stabilizing properties.
    Husum H; Bolwig TG; Sánchez C; Mathé AA; Hansen SL
    Epilepsy Behav; 2004 Apr; 5(2):204-15. PubMed ID: 15123022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affective disorders and functional (non-epileptic) seizures in persons with epilepsy.
    Johnson KA; Macfarlane MD; Looi JC
    Australas Psychiatry; 2016 Dec; 24(6):526-528. PubMed ID: 27329644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stress, conditioning, and the temporal aspects of affective disorders.
    Post RM; Weiss SR; Smith M; Rosen J; Frye M
    Ann N Y Acad Sci; 1995 Dec; 771():677-96. PubMed ID: 8597441
    [No Abstract]   [Full Text] [Related]  

  • 15. Shared mechanisms in affective illness, epilepsy, and migraine.
    Post RM; Silberstein SD
    Neurology; 1994 Oct; 44(10 Suppl 7):S37-47. PubMed ID: 7969945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiepileptic drug augmentation for treatment-resistant depression.
    Feiner NF
    J Clin Psychiatry; 1997 Aug; 58(8):361-3. PubMed ID: 9515976
    [No Abstract]   [Full Text] [Related]  

  • 19. Basic mechanisms of seizure propagation: targets for rational drug design and rational polypharmacy.
    Löscher W; Ebert U
    Epilepsy Res Suppl; 1996; 11():17-43. PubMed ID: 9294726
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of the novel antiepileptic drug lacosamide on the development of amygdala kindling in rats.
    Brandt C; Heile A; Potschka H; Stoehr T; Löscher W
    Epilepsia; 2006 Nov; 47(11):1803-9. PubMed ID: 17116018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.